165 related articles for article (PubMed ID: 1605610)
1. Efficacy of ticarcillin-clavulanic acid for treatment of experimental Staphylococcus aureus endocarditis in rats.
Catherall EJ; Gillon V; Hurn S; Irwin R; Mizen L
Antimicrob Agents Chemother; 1992 Feb; 36(2):458-62. PubMed ID: 1605610
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureus endocarditis in the rat.
Catherall EJ; Irwin R; Mizen LW
J Antimicrob Chemother; 1991 Jan; 27(1):117-26. PubMed ID: 2050588
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.
Boon RJ; Beale AS; Sutherland R
Antimicrob Agents Chemother; 1986 May; 29(5):838-44. PubMed ID: 3524431
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid.
Casey P; Glauser M
Eur J Clin Microbiol; 1983 Dec; 2(6):541-7. PubMed ID: 6607834
[TBL] [Abstract][Full Text] [Related]
5. Antistaphylococcal activity of amoxicillin and ticarcillin when combined with clavulanic acid. Evaluation of oxacillin-resistant and oxacillin-susceptible isolates.
Barry AL
Diagn Microbiol Infect Dis; 1990; 13(5):357-61. PubMed ID: 2282775
[TBL] [Abstract][Full Text] [Related]
6. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
Pefanis A; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
Antimicrob Agents Chemother; 1993 Mar; 37(3):507-11. PubMed ID: 8460919
[TBL] [Abstract][Full Text] [Related]
7. Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci.
Hirano L; Bayer AS
Antimicrob Agents Chemother; 1991 Apr; 35(4):685-90. PubMed ID: 2069374
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
Thauvin-Eliopoulos C; Rice LB; Eliopoulos GM; Moellering RC
Antimicrob Agents Chemother; 1990 May; 34(5):728-32. PubMed ID: 2360813
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ampicillin-sulbactam and ticarcillin-clavulanic acid in patients with chronic renal failure: effects of differential pharmacokinetics on serum bactericidal activity.
Hardin TC; Butler SC; Ross S; Wakeford JH; Jorgensen JH
Pharmacotherapy; 1994; 14(2):147-52. PubMed ID: 8197032
[TBL] [Abstract][Full Text] [Related]
12. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
[TBL] [Abstract][Full Text] [Related]
13. The use of in vitro kinetic models in the evaluation of beta-lactamase inhibitors.
White A; Cooper C; Stokes D
Chemioterapia; 1987 Jun; 6(2 Suppl):202-4. PubMed ID: 3509934
[No Abstract] [Full Text] [Related]
14. [New antimicrobial agent series XXXVII: potassium clavulanate/Ticarcillin sodium].
Fujimori I
Jpn J Antibiot; 1991 Apr; 44(4):365-87. PubMed ID: 1880918
[No Abstract] [Full Text] [Related]
15. Adjunctive Clavulanic Acid Abolishes the Cefazolin Inoculum Effect in an Experimental Rat Model of Methicillin-Sensitive Staphylococcus aureus Endocarditis.
Miller WR; Singh KV; Arias CA; Murray BE
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150459
[TBL] [Abstract][Full Text] [Related]
16. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.
Ramos MC; Ing M; Kim E; Witt MD; Bayer AS
Antimicrob Agents Chemother; 1996 Jan; 40(1):97-101. PubMed ID: 8787887
[TBL] [Abstract][Full Text] [Related]
17. Ticarcillin-clavulanic acid dosing ratio for treatment of experimental Staphylococcus aureus endocarditis.
Goodman JS
Antimicrob Agents Chemother; 1992 Jul; 36(7):1585. PubMed ID: 1510459
[No Abstract] [Full Text] [Related]
18. Rational prescribing of extended-spectrum penicillin beta-lactamase inhibitor combinations: focus on ticarcillin/clavulanic acid.
Reed MD
Ann Pharmacother; 1998 Jan; 32(1):S17-21. PubMed ID: 9475835
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.
Van der Auwera P; Duchateau V; Lambert C; Husson M; Kinzig M; Sörgel F
Antimicrob Agents Chemother; 1993 Sep; 37(9):1860-8. PubMed ID: 8239597
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
Fass RJ; Prior RB
Antimicrob Agents Chemother; 1989 Aug; 33(8):1268-74. PubMed ID: 2552904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
